Interferon treatment is beneficial in early multiple sclerosisBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7265.851/a (Published 07 October 2000) Cite this as: BMJ 2000;321:851
- Fred Charatan
Treatment with interferon beta-1a (Avonex) reduced the rate of development of multiple sclerosis in patients with early signs of the disease by about a half, a study in the New England Journal of Medicine has shown (NEJM 2000;343:898-904).
The study was carried out at 50 US and Canadian hospitals on 383 patients, each of whom had at least one episode of neurological symptoms indicating …
Log in using your username and password
Log in through your institution
Sign up for a free trial